Transient HIV-specific T cells increase and inflammation in an HIV-infected patient treated with nivolumab

AIDS. 2017 Apr 24;31(7):1048-1051. doi: 10.1097/QAD.0000000000001429.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Cytokines / metabolism
  • HIV Infections / pathology*
  • Humans
  • Immunologic Factors / administration & dosage*
  • Inflammation / pathology*
  • Lung Neoplasms / drug therapy
  • Lymphocyte Count
  • Male
  • Middle Aged
  • Nivolumab / administration & dosage*
  • T-Lymphocytes / immunology*
  • Viral Load

Substances

  • Cytokines
  • Immunologic Factors
  • Nivolumab